Washington Trust Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.7K Sell
559
-158
-22% -$12.7K ﹤0.01% 386
2026
Q1
$62.1K Sell
717
-136
-16% -$13K 0.01% 336
2025
Q4
$82K Hold
853
0.01% 304
2025
Q3
$81.3K Buy
853
+117
+16% +$10.8K 0.01% 307
2025
Q2
$64.2K Buy
736
+100
+16% +$8.48K 0.01% 302
2025
Q1
$57.2K Buy
636
+36
+6% +$3.22K 0.01% 310
2024
Q4
$47.9K Hold
600
﹤0.01% 329
2024
Q3
$54K Sell
600
-2,550
-81% -$215K ﹤0.01% 313
2024
Q2
$248K Hold
3,150
0.02% 177
2024
Q1
$275K Buy
3,150
+1,608
+104% +$137K 0.03% 166
2023
Q4
$127K Sell
1,542
-560
-27% -$42.7K 0.01% 223
2023
Q3
$165K Buy
2,102
+140
+7% +$11.7K 0.02% 202
2023
Q2
$173K Buy
1,962
+792
+68% +$68.2K 0.02% 190
2023
Q1
$94.3K Buy
1,170
+153
+15% +$12.5K 0.01% 252
2022
Q4
$79K Sell
1,017
-437
-30% -$35.4K 0.01% 273
2022
Q3
$117K Buy
1,454
+86
+6% +$7.73K 0.01% 254
2022
Q2
$123K Sell
1,368
-2,001
-59% -$203K 0.01% 263
2022
Q1
$373K Sell
3,369
-535
-14% -$56.5K 0.03% 177
2021
Q4
$404K Buy
+3,904
New +$452K 0.03% 179

Other funds holding MDT

Washington Trust Advisors's MDT Position: Q2 2026 in Review

Washington Trust Advisors reduced its Medtronic (MDT) stake by 22% in Q2 2026, selling an estimated $12.7K and leaving 559 shares worth $43.7K. The position accounts for ﹤0.01% of the portfolio, ranked #386.

Washington Trust Advisors first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $404K in Q4 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Washington Trust Advisors held 559 shares of Medtronic worth $43.7K as of Q2 2026.
  • Washington Trust Advisors sold 158 Medtronic shares in Q2 2026, an estimated $12.7K.
  • Medtronic made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #386 holding.
  • Washington Trust Advisors first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
  • Washington Trust Advisors's Medtronic position peaked at $404K in Q4 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.